Overview

Study of ONO-1101 in Patients Scheduled for Coronary Angiography

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of ONO-1101 in patients scheduled for coronary angiography, in a double-blind, randomized, placebo-controlled, parallel group, multi-center study.
Phase:
Phase 2
Details
Lead Sponsor:
Ono Pharmaceutical Co. Ltd
Treatments:
Landiolol